567 results on '"Molina-Infante, Javier"'
Search Results
2. Ultra-short celiac disease exhibits differential genetic and immunophenotypic features compared to conventional celiac disease
3. Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
4. New approaches to diet therapy for eosinophilic esophagitis
5. V Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori
6. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.
7. New entity of adult ultra-short coeliac disease: the first international cohort and case–control study
8. Clinical Practice Guidelines. V Spanish Consensus Conference on Helicobacter pylori infection treatment
9. Efficacy of Dietary Therapy for Eosinophilic Esophagitis in Children and Adults: An Updated Systematic Review and Meta-Analysis.
10. Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection
11. Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients
12. Actualización en el manejo de la infección por Helicobacter pylori. Documento de posicionamiento de la Societat Catalana de Digestologia
13. Esofagitis eosinofílica: diagnóstico y tratamiento actual basado en la evidencia
14. Approaches to diet therapy for eosinophilic esophagitis
15. Quadruple Regimens for Helicobacter pylori Infection
16. Helicobacter pylori Therapy
17. Suspected Nonceliac Gluten Sensitivity Confirmed in Few Patients After Gluten Challenge in Double-Blind, Placebo-Controlled Trials
18. Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study
19. Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study
20. Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis
21. Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis
22. Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments
23. Novedades terapéuticas en la esofagitis eosinofílica
24. Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
25. Four-food group elimination diet for adult eosinophilic esophagitis: A prospective multicenter study
26. Fourteen‐day high‐dose esomeprazole, amoxicillin and metronidazole as third‐line treatment for Helicobacter pylori infection
27. Esophageal dilation in eosinophilic esophagitis: risks, benefits, and when to do it
28. Current treatment options and long-term outcomes in patients with eosinophilic esophagitis
29. Diagnostic and therapeutic management of eosinophilic oesophagitis in children and adults: Results from a Spanish registry of clinical practice
30. Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
31. Seasonal Variation in the Diagnosis of Eosinophilic Esophagitis: There and Back Again
32. Proton Pump Inhibitor Therapy in Eosinophilic Esophagitis: Current Role and Future Perspectives
33. Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy
34. Modifying the natural history of gastrointestinal diseases in Europe as a result of early diagnosis: From eosinophilic esophagitis to inflammatory bowel disease
35. V Spanish Consensus Conference on Helicobacter pylori infection treatment
36. Nutritional and Psychological Considerations for Dietary Therapy in Eosinophilic Esophagitis
37. Esophageal Eosinophilic Infiltration Responds to Proton Pump Inhibition in Most Adults
38. Emerging Therapeutic Strategies for Eosinophilic Esophagitis
39. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis
40. Non-Celiac Gluten Sensitivity
41. Gastric Microbiota
42. Skin testing-directed elimination diet – is 100% efficacy conceivable in eosinophilic esophagitis?
43. Proton pump inhibitor-responsive oesophageal eosinophilia (PPI-REE): characteristics of a Spanish population in central Spain
44. European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain
45. European Registry on Helicobacter pylori management (Hp-EuReg):Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients
46. Nonanesthesiologist-Administered Propofol Versus Midazolam and Propofol, Titrated to Moderate Sedation, for Colonoscopy: A Randomized Controlled Trial
47. Dual response to dietary/topical steroid and proton pump inhibitor therapy in adult patients with eosinophilic esophagitis
48. Eosinophilic esophagitis: a practical approach to diagnosis and management
49. Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice
50. Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.